US Stock MarketDetailed Quotes
ZVSA ZyVersa Therapeutics
- 2.2700
- -0.1600-6.58%
Close Sep 19 16:00 ET
- 2.2701
- +0.0001+0.00%
Post 20:01 ET
2.44MMarket Cap-86P/E (TTM)
2.7100High2.1800Low168.51KVolume2.5400Open2.4300Pre Close401.00KTurnover15.83%Turnover RatioLossP/E (Static)1.07MShares62.300052wk High0.28P/B2.42MFloat Cap2.080052wk Low--Dividend TTM1.06MShs Float8750.0000Historical High--Div YieldTTM21.81%Amplitude2.0800Historical Low2.3790Avg Price1Lot Size
ZyVersa Therapeutics News
Buy Rating Affirmed: ZyVersa Therapeutics' Promising Pipeline and Strategic Advancements
ZyVersa Therapeutics Analyst Ratings
Zyversa Therapeutics' 1-for-35 Reverse Split: Navigating the Risks to Shareholder Value and Liquidity
ZyVersa Therapeutics Analyst Ratings
Analysts Are Bullish on Top Healthcare Stocks: ACELYRIN, INC. (SLRN), ZyVersa Therapeutics (ZVSA)
Buy Rating Affirmed for ZyVersa Therapeutics Amid Promising Inflammatory and Metabolic Syndrome Treatments
HC Wainwright & Co. Initiates Coverage On ZyVersa Therapeutics With Buy Rating, Announces Price Target of $2.5
ZyVersa Therapeutics Analyst Ratings
Analysts Offer Insights on Healthcare Companies: ZyVersa Therapeutics (ZVSA), Halozyme (HALO) and Nurix Therapeutics (NRIX)
No More
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data